Previous work from this laboratory has shown that in patients with multiple sclerosis there is a lowering of the linoleate levels in platelets and erythrocytes (Gul et al., 1970) in addition to a lowering of the linoleate level in the plasma lipids (Belin et al., 1971) , the latter result confirming earlier work (Baker et al., 1964; Tichy et al., 1969) and according with more recent reports (Love et al., 1974; Kalofoutis and Jullien, 1974; Crawford and Hassam, 1975; Paty et al., 1975) , although some authors have failed to find lower linoleate in multiple sclerosis patients (Cumings et al., 1965; Karlsson et al., 1971; Wolfgram et al., 1975) . We have now extended the studies on linoleate levels to lymphocytes and to the free (non-esterified) fatty acids of the plasma. This study is relevant to reports that free fatty acids, especially when they are polyunsaturated, can inhibit certain in vitro activities of lymphocytes (Mertin et al., 1974; Offner and Clausen, 1974) and in vivo can prolong skin graft rejection in rodents (summarised in Hughes et al., 1975) . Mertin et al. (1973) suggested that in vivo these unsaturated acids may play an immunoregulatory role, which may form the basis of the beneficial effect of dietary sunflower seed oil in the treatment of multiple sclerosis (Millar et al., 1973) . (Accepted 30 March 1976.) Further support for the concept that a relationship may exist between fatty acid status and immunological activity arises from work with animals. It has been shown (Clausen and M0ller, 1967; Selivonchick and Johnston, 1975) that animals fed a diet deficient in essential fatty acids (EFA) are more susceptible to the development of experimental allergic encephalomyelitis than those on normal diets and that the addition of linoleate to the diet exerted a pronounced protective effect.
In view of these various findings we thought that it would be valuable to examine the levels of linoleate in the lymphocytes and nonesterified fatty acids of patients with multiple sclerosis and to establish the levels of linoleate in the lymphocytes of rats fed diets in which the linoleate was varied over a wide range. were extracted from the lymphocyte pellet after the final saline wash by resuspending the pellet in 0.5 ml saline and then using the extraction procedure of Folch et al. (1957) . After taking the chloroform layer to dryness the lipid fraction was saponified and the fatty acid composition determined, as described by Belin et al. (1971) . To obtain the free fatty acids 5-ml samples of plasma were extracted by the method of Hagenfeldt (1966) . The methods previously described (Belin et al., 1971) were used for the methylation of the free fatty acids and also for the estimation of the total fatty acids. At weaning the rats were divided into three groups and fed the fat-free diet supplemented with oil as follows: group A, 10% hydrogenated coconut oil; group B, 9% hydrogenated coconut oil plus 1% sunflower seed oil; group C, 10% sunflower seed oil. Control rats were fed the normal cubed diet ad libitum.
The animals were killed when aged 34-36 weeks. Lymphocytes were prepared from the spleen by gentle teasing with forceps in RPMI Medium 1640, then layered on to Lymphoprep (Nyegaard & Co., Oslo), and centrifuged at 400 g for 10 minutes. The cells at the interface were collected and washed three times with RPMI medium 1640 (Flow Laboratories), the first centrifugation being at 180 g for 10 minutes and the subsequent two (to remove platelets) at 100 g for 10 minutes. The pellet was treated in the same way as described above for human lymphocytes.
Rat blood was drawn by heart puncture under light ether anaesthesia and treated for fatty acid determination in the same way as described for human blood.
RESULTS
OBSERVATIONS IN PATIENTS The level of total plasma linoleate when compared with 14 normal control subjects was again found to be significantly lower in this sample of 19 patients (Table 1) , who were randomly selected apart from the need to take those who were not using oil supplements in the diet. A decrease in linoleate was also found in the free fatty acids. Again, a small but significant decrease was found in the lymphocyte fraction. As might be expected, a very close correlation was found between the linoleate levels in the free and total fatty acids (Fig. 1) . (Fig. 2) . It thus appears that there is a correlation (Fig. 3) . It is perhaps not surprising that if the animal is severely deprived of linoleate the acid will be lacking in both lymphocytes and blood. However, even using the results from animals fed sufficient linoleate in the diet-that is, omitting the results from those animals on the EFA deficient diet-a highly significant correlation is found (r=0.75).
DISCUSSION
These and previous results show that lowered linoleate levels are found in the plasma fatty acids, both esterified and free, and in three of the major blood cell types in patients with multiple sclerosis.
The finding, reported for the first time, of a decrease of the linoleate level in the free fatty acids may well be of importance because these are the more likely to influence the level of linoleate in the membrane, since it seems from work with cells in culture that they derive their membrane fatty acids primarily from free fatty acids, although other types of lipids make a small contribution (Bailey et al., 1973) . Furthermore, the observed changes in linoleate in the free fatty acids are more relevant to the in vitro conditions used by Mertin et al. (1974) in their study of the effect of polyunsaturated fatty acids on lymphocyte function.
The question remains to be resolved whether the low levels in the cells arise because of the low plasma levels, since, as we have shown here and previously (Gul et al., 1970) , there is a correlation between levels in plasma and each of these cell types, or whether there is some other cause of the low linoleate levels in cells.
The results further show that lymphocyte linoleate levels are susceptible to change by alteration in diet, and in particular that the feeding of sunflower seed oil to patients will increase the level of linoleate in their lymphocytes. To what extent this is the basis of the beneficial effects reported for the oil is another question to be resolved in the future. It will also be of interest to investigate the effect of these changes on a number of lymphocyte function tests with a view to assessing the extent to which it may be possible to modify by dietary supplementation with linoleate lymphocyte reactivity in patients with multiple sclerosis.
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